This funding round allocated in tranches will strengthen PathoQuest’s position as a leading NGS-based biosafety CRO for the biopharmaceutical industry. Paris, FRANCE, Tübingen, GERMANY – November 9th, 2021 – PathoQuest, a pioneer in the quality control of biologics using Next-Generation Sequencing (NGS), today announced the closing of a financing round up to €15M. This funding […]

Advances in technology are enabling increasingly precise and individualised treatment of diseases.

Senior Investment Manager Dr. Cornelius Maas has joined SHS as a partner with effect from 1 October 2021. With a doctorate in business administration and a former professional handball player, his responsibilities at SHS include deal flow. We are pleased about the promotion of Dr. Cornelius Maas and asked him a few questions about his […]

Experience for the future: Internships at SHS | We offer students a practical experience | private equity and growth companies – learn more!

History of depression “Anxiety and terror by night as well as by day, sleeplessness, blunders, errors, misplaced worries, lack of insight into the actual situation and acting contrary to habit …” – this is how Hippocrates, the most famous physician of antiquity, described depression, which at that time was still called melancholia. The name depression […]

Here we introduce you to the SHS senior advisors. The experience of these experts plays an important role for us in the investment process and benefits not least our portfolio companies. Prof. Dr. med. Marc O. Schurr has been Senior Advisor to SHS since 2020. A graduate in human medicine, he is the founder and […]

Dutch growth company Incision is in the process of building a leading online surgical knowledge platform. Hospitals in 18 countries already use Incision’s online offering. With the purchase of OK Learning’s e-learning modules and performance support tool, Incision is expanding its own knowledge platform with more than 50 new interactive courses and several new features. […]

Since mid-May we welcome Sarah Stelzer at SHS. Born and raised in Tübingen, Sarah is a true native of Tübingen. At SHS, she is responsible for PR and marketing. She takes care of press releases, social media contributions, coordinates projects with our portfolio companies and is also the mouthpiece of SHS to the outside world. […]

A few weeks ago, SHS officially became a member of the United Nations PRI Initiative for Responsible Investment, which was founded in 2006. PRI stands for “Principles for Responsible Investment”. Dr. André Zimmermann is an SHS partner and Head of ESG and thus responsible for socially responsible investing at SHS. We talked to him about […]

In addition to patients suffering from depression, people suffering from generalized anxiety disorder or panic disorder can now also get Selfapy’s online courses free of charge on prescription. This makes Selfapy a pioneer in digital healthcare with three approved digital health apps (DiGA). The aim of Selfapy’s courses is to offer help to sufferers until […]

The systemic use of health data enables the transformation from hypothesis-driven medicine to data-based medicine.

SHS has been investing according to ethical standards for more than 25 years and its ESG policy is an important aspect of investment decisions. Now it is also becoming a member of the PRI (UN Principles for Responsible Investment) The Tübingen-based healthcare investor has committed itself to contractual compliance with the requirements of the UN […]